Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.…
Prenetics Global Limited Q3 2026 Earnings Call Summary
Prenetics Global (NASDAQ: PRE) is listed on Nasdaq, where its shares trade in USD. It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 98 employees.
The shares were at 8.800 USD on 20 November 2026, down 31.9% over 52 weeks. Its 52-week range is 8.700 USD to 27.24 USD: the price is 67.7% below the high and 1.1% above the low.
Its market capitalisation is 171.73M USD.
Prenetics Global reports return on equity of -24.1%, an operating margin of -32.5% and revenue up 172.2% year over year.
It holds more cash than debt, a net cash position of 104.57M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. The next earnings report is expected on 18 February 2027.